Lisa Conroy

Lisa Conroy is the Director of Communications at Antidote. She is a seasoned health communications strategist dedicated to understanding the reasons people make the health choices they do, and determining what that means in terms of how scientific data should be communicated. Prior to her role at Antidote, Lisa ran the TEDMED Great Challenges program, a public health initiative funded by RWJF. She also has experience working in pharmaceutical public relations in the areas of respiratory diseases, oncology, and HIV. Lisa holds an MPH from Columbia and a BA in English and International Studies from Northwestern.

Clinical research in a post-COVID world: Four sites weigh in on the impact of COVID on the future of medical research [whitepaper]

Over the past year and a half, the traditional clinical research model of patient outreach, in-person screening, and site-based follow-up has had to ...

Continue reading

How a 67% randomization rate led to 3 months saved in a Parkinson’s trial [patient recruitment case study]

Parkinson’s disease is a disorder of the central nervous system that affects movement, with symptoms such as tremor, slow movement, stiffness, and ...

Continue reading

COVID-19 and mental health: A look at the pandemic’s impact on mental health, how we’re treating it, and how it’s affecting those in clinical trials [whitepaper]

What impact has COVID-19 had on our collective mental health? How has treatment been adapted to meet new needs? And what does this all mean for ...

Continue reading

Decentralizing research: How reducing patient burden improves trial diversity [whitepaper]

Could the alternative clinical trial approaches necessitated by the COVID-19 pandemic help tip the scales towards fair access to clinical trials? In ...

Continue reading

Patient recruitment: Today’s trends, tomorrow’s potential [interview with ACRPtv]

By some estimations, 80% of clinical trials are delayed or closed because researchers can’t find enough patients to take part in their clinical ...

Continue reading

How to find and join lupus support groups

Living with lupus can be difficult. It’s an “invisible illness” — meaning those around you can’t see your fatigue or your muscle and joint pain or ...

Continue reading

Why your clinical trial advertising might be missing the mark

Are you spending time and money on clinical trial advertising that’s not delivering? It can be frustrating to put resources into spreading the word ...

Continue reading

The evolving role of partnerships in clinical trial patient engagement

An interview with Lindsey Wahlstrom-Edwards, Head of Partnerships at Antidote

Continue reading

How we cut our expected referral timeline in half [patient recruitment case study]

Idiopathic pulmonary fibrosis (IPF) is a progressive disease that causes scarring of the lungs. Over time, the scarring worsens and it can become ...

Continue reading

Patient engagement during COVID-19 [whitepaper]

Does a health crisis change digital engagement behaviors? How should digital marketers respond?

Continue reading

Get our latest posts in your inbox